Ocugen, Inc. (OCGN)
0.7803
-0.03
(-4.10%)
USD |
NASDAQ |
Oct 16, 16:00
0.7996
+0.02
(+2.47%)
After-Hours: 20:00
Ocugen Cash from Investing (Quarterly) : -0.021M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.021M |
| March 31, 2026 | -0.006M |
| December 31, 2025 | -0.035M |
| September 30, 2025 | -0.086M |
| June 30, 2025 | -0.088M |
| March 31, 2025 | -0.102M |
| December 31, 2024 | -0.013M |
| September 30, 2024 | -0.507M |
| June 30, 2024 | -0.513M |
| March 31, 2024 | -2.352M |
| December 31, 2023 | -2.722M |
| September 30, 2023 | -3.365M |
| June 30, 2023 | 5.723M |
| March 31, 2023 | 3.441M |
| December 31, 2022 | -15.30M |
| September 30, 2022 | -0.083M |
| June 30, 2022 | -1.366M |
| March 31, 2022 | -0.223M |
| December 31, 2021 | -0.192M |
| September 30, 2021 | -0.35M |
| June 30, 2021 | -1.013M |
| March 31, 2021 | -0.261M |
| December 31, 2020 | -0.2513M |
| September 30, 2020 | -0.021M |
| June 30, 2020 | 0.0182M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0527M |
| December 31, 2019 | -0.0206M |
| September 30, 2019 | -2.204M |
| June 30, 2019 | -0.1215M |
| March 31, 2019 | -0.0106M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 1.757M |
| June 30, 2018 | -1.479M |
| March 31, 2018 | -0.355M |
| December 31, 2017 | 0.747M |
| September 30, 2017 | 6.104M |
| June 30, 2017 | -0.038M |
| March 31, 2017 | -8.043M |
| December 31, 2016 | -0.003M |
| September 30, 2016 | -0.003M |
| June 30, 2016 | -0.282M |
| March 31, 2016 | -0.032M |
| December 31, 2015 | -0.131M |
| September 30, 2015 | -0.498M |
| June 30, 2015 | -0.405M |
| March 31, 2015 | -0.915M |
| December 31, 2014 | -1.744M |
| September 30, 2014 | -1.384M |
| June 30, 2014 | -0.073M |
| March 31, 2014 | -0.12M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Anika Therapeutics, Inc. | -1.28M |
| Gilead Sciences, Inc. | -10.35B |
| MannKind Corp. | 17.91M |
| Nektar Therapeutics | -399.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.20M |
| Cash from Financing (Quarterly) | 80.37M |
| Free Cash Flow | -61.02M |
| Free Cash Flow Per Share (Quarterly) | -0.0361 |
| Free Cash Flow to Equity (Quarterly) | -66.91M |
| Free Cash Flow to Firm (Quarterly) | -7.743M |
| Free Cash Flow Yield | -24.39% |